Spotlight Therapeutics is Drug Discovery in United States that focus on operator business. Founded in 2017. They cover business area such as operator, therapeutic, vivo gene editing, engineer modular component, cell-target and transmembrane trafficking domain, CRISPR molecule, select cell type, initial program, immuno-oncology, ophthalmology, hematology, a cell, delivery, a one-time injection, healthcare provider.
2017
( 9 years old in 2026 )
Operator
-
3953 Point Eden Way
Hayward, CA 94545
United States
Private
operatortherapeuticvivo gene editingengineer modular componentcell-target and transmembrane trafficking domainCRISPR moleculeselect cell typeinitial programimmuno-oncologyophthalmologyhematologya celldeliverya one-time injectionhealthcare provider
* We use standard office opening hours in near Spotlight Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Spotlight Therapeutics is Drug Discovery business from United States that founded in 2017 (9 years old in 2026), Spotlight Therapeutics business is focusing on Operator.
Spotlight Therapeutics headquarter office and corporate office address is located in 3953 Point Eden Way Hayward, CA 94545 United States.
Spotlight Therapeutics was founded in United States.
In 2026, Spotlight Therapeutics is currently focus on operator sector.
Above is snippet of Google Trends for "operator" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Spotlight Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
